Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia

Clinical trial NCT00790127 · COMPLETED

Trial details

NCT number: NCT00790127
Sponsor: HemaQuest Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Beta Thalassemia

Start date: 2009-03-01
Primary completion: 2010-05-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.